We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aditxt Inc | NASDAQ:ADTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.15 | -6.82% | 2.05 | 2.05 | 2.20 | 2.225 | 1.97 | 2.18 | 24,554 | 23:34:27 |
Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX) announced today it is participating in Edison Group’s Open House Event, scheduled to take place virtually this month.
The three-day event, in association with the London Stock Exchange, global law firm Taylor Wessing, and OpenExchange, will take place between January 25th-27th, focusing on 33 companies. Day one will feature businesses within pharmaceuticals & drug discovery, day two focuses on AI & technology in healthcare, while businesses adopting new approaches to hard-to-solve problems will round off the event.
Content will be available to stream from January 25th on Edison’s website and OpenExchange.tv. Attendance is free and anyone wanting to attend can sign up here: https://www.edisongroup.com/event/edison-open-house-global-healthcare-2022/
For more information on the event and details on how to register, please see below.
Edison Group: Global Healthcare Open House Conference 2022 Date: January 25th-27th, 2022 Edison Group Open House Registration
Presentation information: The company presentation will be available on demand on www.edisongroup.com beginning at 7am ET on Wednesday, January 26th. The presentation will also be available on the Company’s investor relations page.
1x1 Meeting Registration: To register for a 1x1 meeting with the Company, please visit this link.
For any questions about the event or how to register, please reach out to openhouse@edisongroup.com
About Aditxt™
Aditxt develops technologies focused on improving immune system health through immune monitoring and reprogramming. Aditxt’s immune monitoring technology is designed to provide a personalized, comprehensive system immune system profile. Aditxt’s immune reprogramming technology, currently preclinical, is designed to retrain the immune system to induce tolerance to address rejection of transplanted organs, autoimmune diseases, and allergies. AditxtScore™ for COVID-19 is Aditxt’s proprietary immune profile technology to equip people with information about their level of protection. For more information, please visit: www.aditxt.com and www.AditxtScore.com
About Edison Group:
Edison’s leading research and investor relations consultancy connects listed companies to the widest pool of global investors. By focusing on both the volume and quality of investors reached – across institutions, family offices, wealth managers and retail investors, Edison can create and gauge intent to purchase, even in the darkest pools of capital. www.edisongroup.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220114005091/en/
Media and Investor Relations Contact: Edison Investment Research IR@aditxt.com
1 Year Aditxt Chart |
1 Month Aditxt Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions